Total: 13 results found.

Search for:
Search Only:

1. Pre Second World GA68 Congress Publication
(Conferences)
...  Original Articles Ga-68 DOTATATE PET/CT in Neuroendocrine Tumors: Initial Experience   Bhagwant Rai Mittal, Kanhaiyalal Agrawal, Jaya Shukla, Anish Bhattacharya, Baljinder Singh, Ashwani ...
Created on 11 February 2013
2. First World Congress of Ga-68 and PRRNT - an Overwhelming Success
(Conferences)
... of Neuroendocrine Tumors (NETs) using Peptide Receptor RadioNuclide Thearpy (PRRNT).  The event was orginized by Prof. Dr. Richard P. Baum of Zentralklink, Bad Berka and Prof. Dr. Frank Rösch of the Institute ...
Created on 08 September 2011
3. About this site
(Uncategorised)
... Oncology (SIO) and was named SIO Patient Advocate of Year in 2010.  Josh is a member of the National Cancer Institutes's Task force on Neuroendocrine Tumors.  Recently Josh was elected to the board of the ...
Created on 20 January 2011
4. Information for Referring Physicians
(General MD)
... Pancreatic neuroendocrine tumors (pNET), progressive on CT/MRI after Sunitinib/chemotherapy - 2nd line * Functional pNET (e.g. insulinoma, gastrinoma, VIPoma) with persistent, severe clinical symptoms ...
Created on 19 July 2010
5. Nuclear Medicine Specialties
(Nuclear Medicine)
In addition to treating metastatic prostate cancer - Dr. Baum's team treat many of the following cancers with radionuclides: Thyroid cancer with I-131, Neuroblastoma with I-131 MIBG, Bone metastases ...
Created on 19 July 2010
6. New Articles On PRRT
(In the News)
New articles have been added to our file section. Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths. Vikas Prasad & Lisa Bodei & Mark ...
Created on 18 August 2014
7. SNM 2012 Image of the Year: Bi-213-DOTATOC for a New Treatment for GEP-NET Tumors Resistant to Standard Therapies:
(In the News)
Miami Beach, Fla. – The Society of Nuclear Medicine's (SNM) 2012 Image of the Year illustrates the effectiveness of Bi-213-DOTATOC for the peptide receptor alpha-therapy of gastroenteropancreatic neuroendocrine ...
Created on 20 June 2012
8. PET imaging could lead to better care for neuroendocrine cancer
(In the News)
... the Society of Nuclear Medicine's 59th Annual Meeting. Results of the study indicated that PET/CT and Ga-68 DOTATATE was highly sensitive and specific for assessing neuroendocrine tumors and changed ...
Created on 14 June 2012
9. Images from the 1st World Congress on GA-68 and PRRNT
(In the News)
... for individuals with Neuroendocrine tumors as well as other diseases that can be imaged with GA68. Please enjoy the photo gallery below. Viewing on an iPhone, iPad or other device that does not support ...
Created on 24 June 2011
10. Recently Published Articles
(Publications)
... Epub 2011 Mar 29. PubMed PMID: 21445433. 4: Bushnell DL, Baum RP. Standard imaging techniques for neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011 Mar;40(1):153-62, ix. PubMed PMID:1349416. ...
Created on 11 June 2011
11. Jim M.
(Bad Berka)
... or for the following two days. The next day was 'test day'. Blood work, Kidney Function tests, Electrocardiogram, and a special GA-68 PET CT. A very special test that found all of the Neuroendocrine tumors, ...
Created on 22 April 2011
12. Flora
(Bad Berka)
... Flora no longer needs the expensive octreotide medication and she is free of symptoms. As with any cancer treatment, PRRT will yield varying results for patients with neuroendocrine tumors, but, in Flora' ...
Created on 18 April 2011
13. 1st World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy
(In the News)
... important for neuroendocrine cancers such as carcinoid and pancreatic neuroendocrine tumors because, according to Dr. Baum, NET cancer is not one disease. Neuroendocrine tumors are not a single tumor entity, ...
Created on 07 April 2011